15 Low adherence and high rates of discontinuation suggest that there may be significant unmet needs among patients with DED that is not being addressed by the currently available immunomodulatory agents.
← all excerpts
Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye.
1
—
—